Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colchicine for Endothelial Function in NSTEMI
NCT02095522Withdrawn
- Sponsor
- Tel Aviv Sourasky Medical Center
- Start
- Mar 2014
- Primary completion
- Jan 2016
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Randomised, double-blind trial of colchicine in non-ST-elevation myocardial infarction (NSTEMI), sponsored by Tel Aviv Sourasky Medical Center. Primary endpoint: Reactive Hyperemia-Peripheral Arterial Tonometry at 1 month. Planned start Mar 2014; status: withdrawn.
02
Drugs
colchicine
03
Conditions
non-ST-elevation myocardial infarction (NSTEMI)
Beyond the preview
Go deeper on NCT02095522.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02095522.